Catalyst Wire Dossier Catalyst Wire Dossier

IL-YANG Quadrivalent Influenza Vaccine Inj.

· Il-Yang Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-YANG Quadrivalent Influenza Vaccine Inj., covering 2017-02-06 to 2017-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.' [Phase 3]

See pricing